Additional adverse aspect of unrestricted Ang II action during SARS-CoV-2 infection is the increased tendency of thrombosis documented in large number of hospitalized COVID-19 patients (Bikdeli et al., 2020; Klok et al., 2020). This evidence concerns the gene AGT and COVID-19.